Clinical Trials on Type-2 Diabetes in India

Total 869 results

Eli Lilly and Company
Alkermes, Inc.

Completed

Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes

Diabetes Mellitus, Type 1

United States, Belgium, India, Italy, Argentina, France, Germany, Mexico, Puerto Rico
Guerbet

Unknown

Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. (In-Live)

Hemangioendothelioma | Angiosarcoma | Congenital Hemangioma | Arteriovenous Malformation

India
CENTOGENE GmbH Rostock

Completed

Biomarker for Hereditary AngioEdema Disease (BioHAE)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | C1 Esterase Inhibitor Deficiency | HAE | Angio Edema | C4 Deficiency | Hereditary Angioedema Type III

Turkey, Armenia, Georgia, India, Peru, Poland, Romania
Sandoz

Completed

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With BRCA Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

Breast Cancer | Ovarian Cancer

India
GlaxoSmithKline

Completed

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis

India
Medical College and Hospital Kolkata

Completed

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Benign Breast Disease | Mastalgia | Fibroadenoma | Fibrocystic Disease of Breast

India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH) (BioHoFH)

Lipoprotein Lipase Deficiency | Inborn Error of Lipid Metabolism | Corneal Arcus

Germany, India, Sri Lanka
Bharat Biotech International Limited

Completed

COVAXIN in a Pediatric Cohort (COVAXIN-Peds)

SARS-CoV2 Infection

India
KemPharm Denmark A/S

Terminated

Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

Gaucher Disease, Type 1 | Gaucher Disease, Type 3

India
Kowa Research Institute, Inc.
Brigham and Women's Hospital

Terminated

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) (PROMINENT)

Dyslipidemia | Type2 Diabetes

United States, Spain, Canada, Hungary, Netherlands, Brazil, Bulgaria, Poland, Israel, Russian Federation, Ukraine, Denmark, Czechia, South Africa, Argentina, Mexico, United Kingdom, Romania, Germany, India, Slovakia, Japan, Colombia, ... and more
Genzyme, a Sanofi Company

Withdrawn

A Screening Study Evaluating Disease Status of Gaucher Type I Patients

Gaucher Disease, Type 1

United States, India
Eli Lilly and Company
Alkermes, Inc.

Completed

Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes

Diabetes Mellitus, Type 1

United States, Belgium, Canada, Croatia, Hungary, India
Bayer

Completed

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Diabetes Mellitus

Russian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
Ari Zimran
Pfizer

Active, not recruiting

A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease

Gaucher Disease, Type 3

Israel, Turkey, India
Aurigene Discovery Technologies Limited

Completed

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis (INDUS-2)

Chronic Plaque-type Psoriasis

India
Christian Medical College, Vellore, India
Ministry of Science and Technology, India

Unknown

Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (IAPLSG04)

Acute Promyelocytic Leukemia

India
Hospital del Río Hortega

Recruiting

Brain Tumor Intraoperative Ultrasound Database (BraTioUS-DB)

Glioma | Glioblastoma | Brain Neoplasms | Brain Cancer | Brain Tumor

Italy, Spain, India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Wolman Disease (BioWolman) (BioWolman)

Cholesterol Ester Storage Disease | Acid Lipase Deficiency | Acid Cholesteryl Ester Hydrolase Deficiency, Wolman Type

Germany, India, Sri Lanka
Shire

Completed

Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease

Gaucher Disease, Type 3

Egypt, India, Tunisia
Center Trials & Treatment
Oleg Martynenko

Terminated

A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus

COVID-19 | SARS-CoV-2 | Furin | RGMc Processing | Paired Basic Amino Acid Cleaving Enzyme (PACE)

India, United States, Ukraine
GlaxoSmithKline

Completed

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

India
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States, Egypt, India
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer (SPARK)

Squamous Cell Carcinoma of Head and Neck

India
Johnson & Johnson Private Limited

Completed

Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

India
Bayer

Completed

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema (VISION-AF)

Diabetic Macular Edema

India
Bharat Biotech International Limited
Indian Council of Medical Research

Completed

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers (BBV152)

COVID-19 | SARS-CoV-2 Infection

India
Johnson & Johnson Private Limited

Completed

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

India
Gleneagles Hospital
Samsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaborators

Completed

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma (dtZ)

Multiple Myeloma

Korea, Republic of, Singapore, India
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

Leukemia

United States, India
Piramal Enterprises Limited

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

India
Torrent Pharmaceuticals Limited
Iqvia Pty Ltd

Unknown

Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension

Hypertension | Diabetes | Dyslipidemias

Philippines, Brazil, India
Shantha Biotechnics Limited

Completed

Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B

India
Alnylam Pharmaceuticals

Terminated

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

Amyloidosis | Leukocyte Chemotactic Factor 2 Amyloidosis

United States, Malaysia, United Kingdom, Mexico, Egypt, India
Biocad

Completed

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Human Epithelial Receptor (HER)-2 Positive Breast Cancer

Ukraine, Russian Federation, Belarus, India
Eisai Pharmaceuticals India Pvt. Ltd

Completed

A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC

Carcinoma, Hepatocellular

India
Valentin Fuster

Completed

FREEDOM COVID-19 Anticoagulation Strategy (FREEDOM COVID)

COVID-19 | SARS-CoV-2

United States, Colombia, India, Mexico, Brazil
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Hyaline Fibromatosis Syndrome (BioHFS) (BioHFS)

Skin and Connective Tissue Diseases | Hyaline Membrane Disease | Hyalinosis | Juvenile Hyaline Fibromatosis | Fibromatosis Hyalinica Multiplex Juvenilis

Germany, Sri Lanka, India
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Diabetic Foot | Bacterial Infections | Osteomyelitis

China, Colombia, Estonia, Denmark, Taiwan, France, United States, Canada, Spain, Belgium, Austria, Chile, Korea, Republic of, Mexico, Slovakia, United Kingdom, Russian Federation, Croatia, Turkey, Lithuania, Poland, Latvia, Finland, H... and more
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Niemann Pick Type C Disease (BioNPC) (BioNPC)

Niemann-Pick Disease, Type C | Niemann-Pick Disease

Germany, India, Sri Lanka
Pfizer

Completed

A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

India
Novartis Pharmaceuticals

Completed

A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.

Alzheimer's Disease

India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Hurler Disease (BioHurler) (BioHurler)

Metabolism, Inborn Errors | Mucopolysaccharidosis Type I | Gargoylism

Germany, India, Sri Lanka, Egypt
Piramal Enterprises Limited

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)

Melanoma

Australia, India, New Zealand
Amneal Pharmaceuticals, LLC
Accutest Research Laboratories (I) Pvt. Ltd.

Completed

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Chronic Myeloid Leukemia | Gastrointestinal Stromal Tumor

India
Aurigene Discovery Technologies Limited

Recruiting

First in Human, Dose Escalation, Dose Expansion Study of AUR105 (SURYA-1)

Hodgkin Lymphoma | Solid Tumor, Adult | Non-hodgkin Lymphoma

India
Hospices Civils de Lyon

Recruiting

Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma

Peritoneal Malignant Mesothelioma

Belgium, Portugal, France, Germany, India, Norway
The Hospital for Sick Children
Terry Fox Foundation

Active, not recruiting

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

Retinoblastoma

Canada, Chile, India, Singapore
Pfizer

Completed

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

Renal Cell Carcinoma

India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Patients With Fabry Disease (BioFabry) (BioFabry)

Chronic Kidney Disease | Hearing Loss | Angiokeratomas | Ocular Abnormalities

Sri Lanka, India, Germany
Merck Sharp & Dohme LLC

Active, not recruiting

Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)

Melanoma | Carcinoma, Non-Small-Cell Lung

India

Clinical Trials on Type-2 Diabetes in India

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations